Comparing Hair Loss Treatment in Japan and Korea

A doctor’s desk with an open laptop, clipboard and pen, mesh chair, warm shelf lighting, and a green plant

If you’re choosing between Japan and Korea for hair loss treatment, compare specific factors in each country.

Focus on key differences such as the age ranges indicated on medicine labels, the phrasing of insurance policies, and the systems in place for foreign patients.

Contents

Start with your own needs

Before comparing clinics, outline your treatment goals and consider your travel plans. Formulate each item as a question that you can send to each clinic. This approach will help you compare the same criteria in both Japan and Korea.

  • The area of hair loss that bothers you most, as the first thing to describe to a clinic
  • The number of in-person visits you can make, to check against each clinic’s follow-up schedule
  • Whether you want to continue the same medicine after you return home, and what your home country allows
  • The records your local doctor needs from each clinic

How Japan and Korea regulate hair loss treatment

Compare the two treatment options: oral medications and topical minoxidil. The table at the end of this section summarizes the key facts.

Oral medicines need a prescription

In Japan, finasteride and dutasteride are available only by prescription for male-pattern hair loss. The Japanese Dermatological Association’s 2017 guidelines strongly recommend both oral medications and topical minoxidil for men with this condition.

The Japanese prescribing information indicates that safety and effectiveness have not been established for individuals under 20 years old, and it does not specify an upper age limit.

Korea classifies both types of oral medications as prescription drugs. Japan approved finasteride in 2000 for men aged 18 to 41, while it approved dutasteride in 2009 for men aged 18 to 50.

When comparing access in these countries, note that Japan’s guidelines mention only individuals under 20, whereas Korea’s approval information specifies age ranges of 18 to 41 and 18 to 50. Ask the clinic how they determine label ages relative to your actual age.

Independent of prescription regulations, dermatologists in various Asian countries have established a consensus guideline that links hair loss treatment to specific hair loss patterns.

This guideline primarily provides a standardized way to describe your hair loss pattern, but it does not change prescription rules in any country.

A six-month Korean phase 3 study of 153 men aged 18 to 49 years found that the dutasteride group gained a mean of 12.2 hairs per square centimeter and the placebo group gained 4.7.1

That evidence pertains to the medicine, not a comparison between Japan and Korea; it represents findings from a six-month trial rather than a prediction for one patient.

Topical minoxidil without a prescription

In both countries, topical minoxidil is available without a doctor’s prescription to treat male-pattern hair loss. In Japan, it is classified as a medicine that requires pharmacist guidance. Its approved usage is for adult men experiencing male-pattern hair loss.

Consult the pharmacist to understand how it applies to your situation.

In Korea, this medicine is classified as general medicine, which means it is available without a prescription. Apply it to the scalp; do not take it orally. If you need instructions in English, please ask the pharmacy counter before purchasing.

Oral minoxidil is not an approved treatment for hair loss in either country, and Japan’s guidelines specifically advise against its use.

At a glance: Japan and Korea

When reading clinic pages, keep the key facts side by side for easier reference.

ItemJapanKorea
Oral finasteride and dutasteridePrescription-onlyPrescription-only
Topical minoxidilPharmacist-guided, no doctor’s prescription neededGeneral medicine, no doctor’s prescription needed
Public health insuranceNot covered; patients pay the full costExcludes aging-related hair loss that does not interfere with work or daily life
Foreign patient systemAsk each clinic about intake for overseas visitors, language support, and recordsNational registration system with malpractice liability insurance
Medical visaDepends on nationalityC-3-3 for 90 days or less, G-1-10 for up to 1 year

Do not assume either column is the obvious choice. Refer to the table to identify which facts still need confirmation.

What to check as a foreign patient

Start with each country’s insurance rules and, for Korea, the clinic registration system. These frameworks are essential for ensuring patients receive the necessary care and understand their coverage options.

Public health insurance rules

In Japan, public health insurance does not cover hair-loss medications, so patients must pay the full cost out of pocket. In Korea, the National Health Insurance system classifies treatment for hair loss due to aging as a non-covered service, provided it does not interfere with work or daily life.

Notably, the policy does not specifically mention male-pattern baldness. Confirm with the clinic whether your planned treatment will require out-of-pocket payment.

Korea registers clinics that treat foreign patients

Korea has a national registration system for hospitals and clinics that treat foreign patients. Since 2016, all registered institutions must have medical malpractice liability insurance. Before making an appointment, ask the clinic for its registration number, then verify it on the government website.

For Japan, ask the clinic about its visitor intake process, including how it manages bookings and check-ins for patients traveling from outside the country, as well as the availability of language support and access to medical records.

Check visa rules for your nationality

Entry rules vary based on nationality, and clinics cannot guarantee visa approval. Use the two stay lengths below to clarify the rules.

Short stays

Whether you need a visa for Japan depends on your nationality. A Japanese embassy or consulate can inform you about the specific rules that apply to you. South Korea allows visa-free entry for certain travelers and provides a C-3-3 medical visa for those seeking treatment or travel for up to 90 days.

Longer medical stays

For extended stays, Korea’s G-1-10 medical visa allows for long-term treatment and recovery for up to one year. Verify eligibility, required documents, fees, and processing times with the embassy or consulate of the country you are planning to visit.

Ask about continuing treatment after you return home

Send the same questions to shortlisted clinics in both countries. Emphasize care after the initial visit, as hair loss treatment typically continues for several months.

Please ask the doctor how they confirm the diagnosis and how often you will need to return for follow-up visits. Also, inquire whether you can use or refill a prescription provided during the visit after returning home.

Additionally, request a written diagnosis and the ingredient names in English so your local doctor can continue your care.

In Japan, doctors typically assess the effectiveness of two oral medications after about six months. It’s advisable to ask the clinic how long they expect you to continue treatment.

In a large European Union survey of people treated abroad, 12% of those who were prescribed a medicine abroad reported problems with an unfamiliar product, getting the medicine, or reimbursement.2

Records can fail in both directions. Before you travel, ask the clinic what it needs from your home doctor and send those records ahead; in a small Dutch survey, 63% of people treated abroad said their records had not reached the foreign clinic before treatment.3

Before you leave, ask for a written diagnosis and the ingredient names in English; the same survey found that 22% were initially refused follow-up care at home.3

During a short trip to Japan, you can meet with our doctors in person at our clinics located in Tokyo and Yokohama. Once your results are stable and the doctor approves, you can choose online follow-ups from home.

Please note that while consultations can be conducted online, we cannot ship medical supplies or prescriptions internationally.

Frequently asked questions

Do I need a prescription for hair loss treatment in Japan and Korea?

For oral finasteride and dutasteride, both countries require a doctor’s prescription. Topical minoxidil is an exception and can be purchased without a doctor’s prescription.

Can public health insurance cover treatment in either country?

In general, patients in Japan pay the full cost of treatment. In Korea, regulations do not cover aging-related hair loss unless it interferes with work or daily life; please confirm the pricing of your intended treatment with the clinic.

Which visa should I choose for a medical visit?

Visa rules vary based on nationality. If you are traveling to Japan, consult a Japanese embassy or consulate to determine which visa type suits your plans. For Korea, the medical visas include C-3-3 for stays of up to 90 days and G-1-10 for stays of up to one year.

Can I bring several months of hair loss medicine home?

Medication regulations depend on your home country’s rules, not just the clinic’s policies. Before getting a prescription, check with your country’s drug regulatory authority or customs office to understand quantity limits and required documentation.

While the clinic can provide ingredient names and a written record, it cannot determine what customs will permit.

References

1. Eun, H. C., Kwon, O. S., Yeon, J. H., Shin, H. S., Kim, B. Y., Ro, B. I., Cho, H. K., Sim, W. Y., Lew, B. L., Lee, W. S., Park, H. Y., Hong, S. P., & Ji, J. H. (2010). Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. Journal of the American Academy of Dermatology, 63(2), 252-8. https://doi.org/10.1016/j.jaad.2009.09.018

2. Panteli, D., Wagner, C., Verheyen, F., & Busse, R. (2015). Continuity of care in the cross-border context: insights from a survey of German patients treated abroad. European Journal of Public Health, 25(4), 557-63. https://doi.org/10.1093/eurpub/cku251

3. Verra, S. E., Kroeze, R., & Ruggeri, K. (2016). Facilitating safe and successful cross-border healthcare in the European Union. Health Policy, 120(6), 718-27. https://doi.org/10.1016/j.healthpol.2016.04.014

Manabe, M., Tsuboi, R., Itami, S., Osada, S. I., Amoh, Y., Ito, T., Inui, S., Ueki, R., Ohyama, M., Kurata, S., Kono, T., Saito, N., Sato, A., Shimomura, Y., Nakamura, M., Narusawa, H., Yamazaki, M., & Drafting Committee for the Guidelines for the Diagnosis and Treatment of Male- and Female-Pattern Hair Loss (2018). Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. The Journal of Dermatology, 45(9), 1031-1043. https://doi.org/10.1111/1346-8138.14470

Choi, S., Kwon, S. H., Sim, W. Y., & Lew, B. L. (2024). Long-term efficacy and safety of dutasteride 0.5 mg in Korean men with androgenetic alopecia: 5-year data demonstrating clinical improvement with sustained efficacy. The Journal of Dermatology, 51(5), 684-690. https://doi.org/10.1111/1346-8138.17138

Lee, W. S., Lee, H. J., Choi, G. S., Cheong, W. K., Chow, S. K., Gabriel, M. T., Hau, K. L., Kang, H., Mallari, M. R., Tsai, R. Y., Zhang, J., & Zheng, M. (2013). Guidelines for management of androgenetic alopecia based on BASP classification–the Asian Consensus Committee guideline. Journal of the European Academy of Dermatology and Venereology, 27(8), 1026-1034. https://doi.org/10.1111/jdv.12034

Share this article
  • URL copied!
  • URL copied!
Contents